This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 1.68B 648.72M 535.61M 230.28M
Receivables 1.47B 1.02B 891.78M 693.12M
Inventories 238.58M 128.86M 70.35M 28.64M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 3.85B 2.17B 1.80B 1.21B
Property, Plant & Equipment, Gross 1.59B 1.23B 748.60M 560.45M
Accumulated Depreciation & Depletion n.a. 253.98M 221.62M 180.51M
Property, Plant & Equipment, Net 1.59B 974.31M 526.98M 379.94M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 169.31M 463.19M 395.22M 302.52M
Total Non-Current Assets 1.76B 1.70B 1.15B 874.48M
Liabilities & Shareholder Equity
Total Assets 5.61B 3.87B 2.95B 2.08B
Accounts Payable 760.62M 99.51M 61.94M 38.93M
Short Term Debt 0.00 0.00 939.00K 1.37M
Other Current Liabilities 0.00 96.41M 0.00 0.00
Total Current Liabilities 1.58B 654.66M 298.83M 163.55M
Long Term Debt 10.80M 146.77M 320.31M 296.52M
Deferred Income Taxes n.a. 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 217.13M 195.53M 215.60M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 375.51M 674.84M 700.10M 671.55M
Total Liabilities 1.95B 1.33B 998.94M 835.11M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 3.65B 2.54B 1.95B 1.25B
Common Par n.a. 104.00K 99.00K 97.00K
Additional Paid In Capital 0.00 2.40B 2.05B 1.76B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 255.38M -92.69M -517.05M
Treasury Stock n.a. -169.53M 0.00 0.00
Other Equity Adjustments 3.65B 52.25M -1.19M -1.17M
Total Capitalization 3.67B 2.69B 2.27B 1.54B
Total Equity 3.65B 2.54B 1.95B 1.25B
Total Liabilities & Stock Equity 5.61B 3.87B 2.95B 2.08B
Total Common Shares Outstanding 104.07M 102.43M 99.69M 97.29M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 2.02M 0.00 0.00
Basic Weighted Shares Outstanding 103.06M 100.61M 97.92M 94.69M
Diluted Weighted Shares Outstanding 115.23M 113.41M 111.29M 115.38M
Number of Employees NA 2925 2340 1950
Number of Part-Time Employees NA 0 0 0
REGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

REGN Regeneron Pharmaceuticals Inc

Chart of REGN

Analysts Ratings for REGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 7 7 6
Moderate Buy 2 2 2 2
Hold 7 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
GET REGN ANALYST REPORT

REGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs